65 related articles for article (PubMed ID: 11393680)
21. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
23. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
24. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo.
Wei CC; Ferrario CM; Brosnihan KB; Farrell DM; Bradley WE; Jaffa AA; Dell'Italia LJ
J Pharmacol Exp Ther; 2002 Jan; 300(1):324-9. PubMed ID: 11752132
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue.
Barthelemy C; Eurin J; Lechat P; Masson F; Cortines M; Mougenot N; Soualmia H; Carayon A
Peptides; 2002 Jun; 23(6):1161-9. PubMed ID: 12126746
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs.
Maniatis NA; Balyasnikova IV; Metzger R; Castellon M; Visintine DJ; Schwartz DE; Minshall RD; Danilov SM
Microvasc Res; 2010 Sep; 80(2):250-7. PubMed ID: 20430040
[TBL] [Abstract][Full Text] [Related]
28. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.
Xiao HD; Fuchs S; Campbell DJ; Lewis W; Dudley SC; Kasi VS; Hoit BD; Keshelava G; Zhao H; Capecchi MR; Bernstein KE
Am J Pathol; 2004 Sep; 165(3):1019-32. PubMed ID: 15331425
[TBL] [Abstract][Full Text] [Related]
29. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats.
Wei CC; Lucchesi PA; Tallaj J; Bradley WE; Powell PC; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H784-92. PubMed ID: 12663259
[TBL] [Abstract][Full Text] [Related]
30. Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo.
Campbell DJ; Xiao HD; Fuchs S; Bernstein KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):547-53. PubMed ID: 19673938
[TBL] [Abstract][Full Text] [Related]
31. In vivo measurement of coronary circulation angiotensin-converting enzyme activity in humans.
Staniloae C; Schwab AJ; Simard A; Gallo R; Dyrda I; Gosselin G; Lesperance J; Ryan JW; Dupuis J
Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H17-22. PubMed ID: 12485815
[TBL] [Abstract][Full Text] [Related]
32. Surfactant protein A (SP-A) and angiotensin converting enzyme (ACE) as early biomarkers for pulmonary edema formation in ventilated human lung lobes.
Gnadt M; Kardziev B; Schmidt M; Högger P
Lung; 2012 Aug; 190(4):431-40. PubMed ID: 22466057
[TBL] [Abstract][Full Text] [Related]
33. Role of lipoxygenase products in the effects of angiotensin II in the isolated aorta and perfused heart of the rat.
Dam JP; Worm E; Vleeming W; Post MJ; Porsius AJ; Wemer J
Mediators Inflamm; 1995; 4(6):417-25. PubMed ID: 18475674
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three methods for collecting interstitial fluid from subcutaneous tissue in mini pigs.
Xiong F; Zheng Y; Ouyang Y; Song X; Jia S; Wang G; Wang S; Liu Q; Zhao J; Zhang W
MethodsX; 2024 Jun; 12():102700. PubMed ID: 38633419
[TBL] [Abstract][Full Text] [Related]
35. Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.
Reid AC; Brazin JA; Morrey C; Silver RB; Levi R
Curr Pharm Des; 2011 Nov; 17(34):3744-52. PubMed ID: 22103845
[TBL] [Abstract][Full Text] [Related]
36. Aliskiren: the first direct renin inhibitor for hypertension.
van den Meiracker AH; Jan Danser AH
Curr Cardiol Rep; 2007 Nov; 9(6):470-6. PubMed ID: 17999872
[TBL] [Abstract][Full Text] [Related]
37. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Mackins CJ; Kano S; Seyedi N; Schäfer U; Reid AC; Machida T; Silver RB; Levi R
J Clin Invest; 2006 Apr; 116(4):1063-70. PubMed ID: 16585966
[TBL] [Abstract][Full Text] [Related]
38. Mast cells: a unique source of renin.
Silver RB; Reid AC; Mackins CJ; Askwith T; Schaefer U; Herzlinger D; Levi R
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13607-12. PubMed ID: 15342908
[TBL] [Abstract][Full Text] [Related]
39. Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
Schuijt MP; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Br J Pharmacol; 2002 Jan; 135(1):275-83. PubMed ID: 11786504
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart.
de Lannoy LM; Schuijt MP; Saxena PR; Schalekamp MA; Danser AH
J Hypertens; 2001 May; 19(5):959-65. PubMed ID: 11393680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
